Skip to main content
Equibles

STEMPOINT CAPITAL LP

Position in IFRX — InflaRx N.V.

CIK 1952142 NEW YORK, NY
Back to IFRX Full portfolio

Position in IFRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$7,231,291
+$6,491,772 QoQ
Shares Held
3,228,255
+345.3% QoQ
Ownership
2.19%
of shares outstanding
% of Portfolio
1.25%
of 13F equity value
Holder Rank
#8
of 62 holders
Holding Since
Mar 2025
2 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $524,439,182 across 65 Biotechnology names. IFRX ranks #23 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TNGX
Tango Therapeutics, Inc.
 1,223,019 $38,231,573
2 ABVX
Abivax S.A.
 283,657 $37,800,131
3 RVMD
Revolution Medicines, Inc.
 159,943 $29,954,125
4 ERAS
Erasca, Inc.
 1,565,913 $28,687,526
5 TYRA
Tyra Biosciences, Inc.
 632,754 $20,210,162
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 200,851 $19,578,955
7 ELVN
Enliven Therapeutics, Inc.
 346,914 $17,605,885
8 MLYS
Mineralys Therapeutics, Inc.
 602,686 $16,260,468

All Filings in IFRX

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,231,291 3,228,255
2025-03-31 $739,519 725,019